Ximin Chi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ximin Chi

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Acta Pharmaceutica Sinica. B|February 13, 2026

Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1Taoling Zeng, Tingting Jiang, Baoding Zhang, et al.

Cell Discovery|April 4, 2023

Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variantsXiangyang Chi, Lingyun Xia, Guanying Zhang, et al.

Nature Biotechnology|September 10, 2025

A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2Yankai Chu, Shishuang Chen, Mingyang Yang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Acta Pharmaceutica Sinica. B|February 13, 2026

Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1Taoling Zeng, Tingting Jiang, Baoding Zhang, et al.

Cell Discovery|April 4, 2023

Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variantsXiangyang Chi, Lingyun Xia, Guanying Zhang, et al.

Nature Biotechnology|September 10, 2025

A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2Yankai Chu, Shishuang Chen, Mingyang Yang, et al.

Pageof 2